Endocrine & metabolic denials at external review

• among the highest

  At 78.1%, this is the highest overturn rate of the 24 conditiones with enough decisions to publish one. Reviewers sustained the plan in the remaining 21.9% of disputes.

• the question matters

  The outcome turns on which question was put to the reviewer: 79.9% on medical necessity (n=1,940) against 54.4% on experimental/investigational (n=149) — a gap of 26 points inside the same condition.

• rising

  It has risen over the published record: 36.7% in 2003 against 83.3% in 2025. What drove that is not in this data — the file holds outcomes, not who chose to appeal or how plans changed their own review.

• most-cited standard

  Reviewers named FDA more than any other standard here — 923 decisions, which came out at 83.9%. Citing a standard and the outcome share a cause; this is not the effect of naming it.

California requires each published decision to carry “a detailed case summary that includes the specific standards, criteria, and medical and scientific evidence, if any, that led to the case decision” (Health & Safety Code § 1374.33(h)(1)(K)). These are the elements our extraction found in this class, split by how the decision came out.

Read as description, not instruction. These are patterns in what reviewers wrote, not steps to follow, and no combination of them predicts an outcome. Only codes that cleared the validation gate appear — thirteen did not.

• FDA83.9%923
• American Diabetes Association65.5%84
• American College of Cardiology26.7%30
• American Gastroenterological Association—23
• American Heart Association—22
• American Society of Plastic Surgeons—11
• American Urological Association—9
• American Academy of Pediatrics—4

A rate here is the outcome of decisions that named the authority, not the effect of naming it. Reviewers cite the standard they applied; the citation and the outcome share a cause.

• Pharmacy82.3%1,782
• Durable medical equipment67.9%106
• Diagnostic imaging & screening26.6%64
• Reconstructive & plastic procedures52.2%46
• General surgery53.5%43
• Electro, thermal & radiofrequency—14
• Special procedures—8
• Skilled nursing & inpatient rehab—6

Browse all treatment classes · Pick your own pair

• Weight Control87.7%1,350
• Diabetic Medication78.2%216
• Hormones50.0%112
• Glucose Monitor75.8%91
• Other50.0%40
• Cardiac Rx34.3%35
• Bariatric Surgery62.5%32
• Liposuction—28

• Medical Necessity79.9%1,940
• Experimental/Investigational54.4%149

Medical-necessity review asks whether the care is needed. Experimental/investigational review asks whether it is likely to be more beneficial than standard therapy — a harder statutory test, and the rates show it.